Ke Zhou

904 total citations
42 papers, 472 citations indexed

About

Ke Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ke Zhou has authored 42 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Ke Zhou's work include Cancer-related molecular mechanisms research (5 papers), COVID-19 and healthcare impacts (5 papers) and Circular RNAs in diseases (4 papers). Ke Zhou is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), COVID-19 and healthcare impacts (5 papers) and Circular RNAs in diseases (4 papers). Ke Zhou collaborates with scholars based in China, France and Madagascar. Ke Zhou's co-authors include Wenqi Zhang, Geng Wang, Qin Ou, Khee Chee Soo, Zhongcheng Huang, Soon Thye Lim, Joanne Ngeow, Zhigang Xiao, Yang Zhang and Xiong Guo and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Ke Zhou

40 papers receiving 470 citations

Peers

Countries citing papers authored by Ke Zhou

Since Specialization

Citations

This map shows the geographic impact of Ke Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Zhou more than expected).

Fields of papers citing papers by Ke Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Zhou. The network helps show where Ke Zhou may publish in the future.

Co-authorship network of co-authors of Ke Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Zhou. A scholar is included among the top collaborators of Ke Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Zhou. Ke Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MgFe-LDH nanocomposites incorporated into gelatin methacryloyl /hyaluronic acid methacrylated hydrogels for controlled drug release: Synergistic regulation of angiogenesis−osteogenesis for bone regeneration 2026 ·International Journal of Biological Macromolecules ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ke Zhou, (unknown), (unknown), (unknown)	0
2	AMPK: An energy sensor for non-small cell lung cancer progression and treatment 2025 ·Pharmacological Research ·(unknown), Xuyan Wang, Ying Pan, Ke Zhou, Jinbo Chen, Yuqi Gao, Bo Dai, Zhiling Zhou, Ruiqi Wang	4
3	Human serum albumin and sialic acid co-modified liposome nanoreactors with tumor-specific activable cascade reactions for cooperative cancer therapy 2024 ·Journal of Drug Delivery Science and Technology ·(unknown), Ke Zhou, Yuanyuan Li, Haoxin Li, (unknown), Lingbing Li, Wei Xu	2
4	Factors Influencing Adherence to the Risk Management Program for Women With a Genetic Predisposition to Breast Cancer: Real-World Data from a French Multicenter Program 2024 ·The Oncologist ·Ke Zhou, M. Bellanger, (unknown), (unknown), Charlotte Huët, Caroline Abadie	1
5	The effect of vitamin D on the lipid profile in individuals with overweight or obesity: A meta-analysis and systematic review of randomized controlled trials 2024 ·Prostaglandins & Other Lipid Mediators ·Kuang‐Hui Yu, Wentao Song, (unknown), Ke Zhou, Kousalya Prabahar	4
6	Compound Chinese medicine (F1) improves spleen deficiency diarrhea by protecting the intestinal mucosa and regulating the intestinal flora 2024 ·Frontiers in Microbiology ·Kang Wang, (unknown), Zhi Yang, Fu‐Mei Yang, (unknown), Gang Duan, (unknown), Ke Zhou, Jun He, (unknown)	5
7	ROS-responsive Hydrogel Loaded with Allicin Suppresses Cell Apoptosis for the Treatment of Intervertebral Disc Degeneration in a Rat Model 2024 ·World Neurosurgery ·Ting Zhang, Qing Huang, (unknown), Ke Zhou, Keqi Hu, Kaifeng Gan	1
8	Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study 2024 ·PLoS ONE ·Ke Zhou, Marie Robert, (unknown), Audrey Blanc-Lapierre, (unknown), Frédéric Bigot, Jean‐Sébastien Frenel, Mario Campone, Thierry Conroy, Frédérique Penault‐Llorca, Jean‐Luc Raoul, M. Bellanger	1
9	COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19) 2023 ·Cancers ·Valérie Seegers, Guillaume Rousseau, Ke Zhou, Audrey Blanc-Lapierre, Frédéric Bigot, Hakim Mahammedi, Aurélien Lambert, (unknown), Mario Campone, Thierry Conroy, Frédérique Penault‐Llorca, M. Bellanger, Jean‐Luc Raoul	2
10	Follicular DNA Damage and Pesticide Exposure Among Latinx Children in Rural and Urban Communities 2023 ·Exposure and Health ·(unknown), Mohamed Gaber, Ke Zhou, Haiying Chen, (unknown), Phillip Summers, Kim A. Anderson, Richard P. Scott, Carey Pope, (unknown), Paul J. Laurienti, Sara A. Quandt, Thomas A. Arcury, Pierre‐Alexandre Vidi	1
11	RapaLink-1 outperforms rapamycin in alleviating allogeneic graft rejection by inhibiting the mTORC1-4E-BP1 pathway in mice 2023 ·International Immunopharmacology ·Ning Wang, Ke Zhou, (unknown), Ruiqi Sun, Hong Tang, Zhentao Yang, Wentao Zhao, (unknown), Penghong Song, Shusen Zheng, Haiyang Xie	6
12	A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantation 2023 ·EBioMedicine ·Zhentao Yang, Haiyang Xie, Jianqin Wan, (unknown), Liang Zhang, Ke Zhou, Hong Tang, Wentao Zhao, Hangxiang Wang, Penghong Song, Shusen Zheng	4
13	Association between pretreatment C-reactive protein level and survival in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis 2023 ·International Immunopharmacology ·(unknown), (unknown), Ke Zhou, Suyan Wang, Cheng Cheng, Dan Liu, Weimin Li	11
14	Loss of GLTSCR1 causes congenital heart defects by regulating NPPA transcription 2023 ·Angiogenesis ·Fengyan Han, Beibei Yang, Yan Chen, (unknown), Xiaoqing Cheng, Jiaqi Huang, Ke Zhou, Dandan Zhang, Enping Xu, Maode Lai, Bingjian Lv, Hongqiang Cheng, Honghe Zhang	6
15	COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19) 2022 ·Cancers ·Valérie Seegers, Guillaume Rousseau, Ke Zhou, Audrey Blanc-Lapierre, Frédéric Bigot, Hakim Mahammedi, Aurélien Lambert, (unknown), Mario Campone, Thierry Conroy, Frédérique Penault‐Llorca, M. Boisdron‐Celle, M. Bellanger, Jean‐Luc Raoul	2
16	Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients—First Results from the PAPESCO-19 Cohort Study 2021 ·Cancers ·Ke Zhou, Audrey Blanc-Lapierre, Valérie Seegers, M. Boisdron‐Celle, Frédéric Bigot, (unknown), Hakim Mahammedi, Aurélien Lambert, Mario Campone, Thierry Conroy, Frédérique Penault‐Llorca, M. Bellanger, Jean‐Luc Raoul	6
17	An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network 2019 ·Breast Cancer Research and Treatment ·Min Sun, Di Wu, Ke Zhou, Heng Li, Xingrui Gong, Qiong Wei, (unknown), (unknown), (unknown), Hongrui Zhu, Xinsheng Gu, Dong Huang	28
18	Long noncoding RNA hypoxia-inducible factor 1 alpha-antisense RNA 1 promotes tumor necrosis factor-α-induced apoptosis through caspase 3 in Kupffer cells 2018 ·Medicine ·(unknown), Jiguang Ding, Qingfeng Sun, Ke Zhou, Weiwei Zhang, Qingwei Du, Ting‐Yan Xu, (unknown)	17
19	Sanguinarine protects against ovariectomy-induced osteoporosis in mice 2017 ·Molecular Medicine Reports ·Yan Ma, (unknown), Jianjun Ma, Lei Ning, Ke Zhou, Xiangqian Fang	3
20	Inhibition of the mevalonate pathway ameliorates anoxia-induced down-regulation of FKBP12.6 and intracellular calcium handling dysfunction in H9c2 cells 2015 ·Journal of Molecular and Cellular Cardiology ·Ying Yang, Xue Lu, (unknown), (unknown), Dongwu Lai, Yan Ma, Ke Zhou, Guosheng Fu, Shiming Xu	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact